OKYO Pharma OKYO
NASDAQ OKYO
$1.47 -0.07 (-4.55%)
At close: Oct 22, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Net Cash Flow (2025 - 2026)

Updated

OKYO Pharma's Net Cash Flow came in at $1.22 billion for the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Net Cash Flow (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma's Net Cash Flow was $13.08 million.

  • Net Cash Flow carries a five-year compound annual growth rate of -93.1% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Net Cash Flow was -$1.21 billion in the year ended Mar 31, 2025, -$3.28 million in the year ended Dec 31, 2024, -$5.91 billion in the year ended Dec 31, 2023 and -$4.53 trillion in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -3.52 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -2.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.94 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -4.43 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -722.00 Mn
10 OKYO Pharma 985.60 Mn 958.83 Mn - 1.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.22 Bn
Dec 31, 2025 -1.94 Mn
API Access

OKYO Pharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=OKYO&period=max&api_key=YOUR_API_KEY